Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant SANOFI-AVENTIS DEUTSCHLAND GMBH, against the decision of the State Institute for Drug Control from e 3. 3. 2020, under the no. SUKLS298091/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant B. Braun Melsungen AG, against the decision of the State Institute for Drug Control from 07.02.2020, under the no.: SUKLS293518/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant AstraZeneca AB, against the decision of the State Institute for Drug Control from 5.2.2020, under the no.: SUKLS314006/2018:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 29. 6. 2022, under the no: SUKLS247998/2021:

• the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant ViiV Healthcare BV, against the decision of the State Institute for Drug Control from 24. 2. 2021, under the no. SUKLS5340/2021:

• the appeals are dismissed as inadmissible.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Celltrion Healthcare Hungary Kft. and AbbVie Deutschland GmbH & Co. KG, against the decision of the State Institute for Drug Control from 23. 5. 2019, under the no. SUKLS256885/2017:

• the decision under appeal is partially reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Union of Health Insurance companies, against the decision of the State Institute for Drug Control from 9. 1. 2020, under the no. SUKLS213802/2014:

• the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
  

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 20. 11. 2019, under the no.: SUKLS238891/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.